Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

DURLAZA

ASPIRIN

Standard Dose
162.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DURLAZA is listed in Drugs@FDA under application 200671 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ASPIRIN Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 162.5MG Sponsor HESP Submission history Latest submission status date: 2015-09-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview DURLAZA is listed in Drugs@FDA under application 200671 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ASPIRIN Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 162.5MG Sponsor HESP Submission history Latest submission status date: 2015-09-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.